MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Genelux Corporation - Common Stock (NQ:GNLX)

2.700 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 35
Open 2.700
Bid (Size) 2.800 (400)
Ask (Size) 2.900 (100)
Prev. Close 2.700
Today's Range 2.700 - 2.700
52wk Range 1.988 - 8.535
Shares Outstanding 38,051,771
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
These stocks are gapping in today's session ↗
Via Chartmill
News headline image
Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock
From Genelux Corporation
Via GlobeNewswire

Performance

YTD
-40.7%
-40.7%
1 Month
-40.7%
-40.7%
3 Month
-52.4%
-52.4%
6 Month
-21.5%
-21.5%
1 Year
+5.9%
+5.9%

More News

Read More
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill
News headline image
The Great Thaw: Biotech Fundraising Surges as Monte Rosa and Genelux Tap Reopening Markets
Via MarketMinute
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
Genelux Corporation Announces Proposed Public Offering of Common Stock
From Genelux Corporation
Via GlobeNewswire
News headline image
Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials
From Genelux Corporation
Via GlobeNewswire
News headline image
Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer
From Genelux Corporation
Via GlobeNewswire
News headline image
Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference
From Genelux Corporation
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates
From Genelux Corporation
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference
From Genelux Corporation
Via GlobeNewswire
News headline image
Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates
From Genelux Corporation
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
News headline image
Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development
From Genelux Corporation
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates
From Genelux Corporation
Via GlobeNewswire
News headline image
Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference
From Genelux Corporation
Via GlobeNewswire
News headline image
Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
From Genelux Corporation
Via GlobeNewswire
News headline image
CurrencyNewsBreaks – Titan Partners Group LLC Acts as Sole Bookrunner for $10.5M Underwritten Offering
Via Investor Brand Network
Topics Economy
News headline image
Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock
From Genelux Corporation
Via GlobeNewswire
News headline image
Genelux Announces Alignment with FDA on Key Elements of the Approval Pathway for Olvi-Vec in Platinum Resistant/Refractory Disease
From Genelux Corporation
Via GlobeNewswire
News headline image
Genelux and Newsoara Announce Positive Preliminary Phase 1b/2 Data of Olvi-Vec in Advanced Small-Cell Lung Cancer
From Genelux Corporation
Via GlobeNewswire
News headline image
Genelux Corporation Announces New Chief Financial Officer
From Genelux Corporation
Via GlobeNewswire
News headline image
Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright
From Genelux Corporation
Via GlobeNewswire

Frequently Asked Questions

Is Genelux Corporation - Common Stock publicly traded?
Yes, Genelux Corporation - Common Stock is publicly traded.
What exchange does Genelux Corporation - Common Stock trade on?
Genelux Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Genelux Corporation - Common Stock?
The ticker symbol for Genelux Corporation - Common Stock is GNLX on the Nasdaq Stock Market
What is the current price of Genelux Corporation - Common Stock?
The current price of Genelux Corporation - Common Stock is 2.700
When was Genelux Corporation - Common Stock last traded?
The last trade of Genelux Corporation - Common Stock was at 01/08/26 04:00 PM ET
What is the market capitalization of Genelux Corporation - Common Stock?
The market capitalization of Genelux Corporation - Common Stock is 102.74M
How many shares of Genelux Corporation - Common Stock are outstanding?
Genelux Corporation - Common Stock has 103M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story